Mon, October 3, 2022

Francois Brisebois Upgraded (SNSE) to Buy and Held Target at $5 on, Oct 3rd, 2022

Francois Brisebois of Oppenheimer, Upgraded "Sensei Biotherapeutics, Inc." (SNSE) to Buy and Held Target at $5 on, Oct 3rd, 2022.

Francois, nor any peers, have made any analyst calls on SNSE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30